Anatomical and Functional Outcomes of Vitrectomy with/without Intravitreal Methotrexate Infusion for Management of Proliferative Vitreoretinopathy Secondary to Rhegmatogenous Retinal Detachment

Table 4

Effect of lens status on anatomical outcome in each subgroup and control.

Lens status				Anatomical outcome		value
				Successful	Recurrent
				count	count
Subgroups based on MTX indication	Control 1	Lens status	Pseudophakic	23	2	0.1
			Aphakic	0	0
			Phakic	3	2
	Established PVR	Lens status	Pseudophakic	14	7	0.3
			Aphakic	1	1
			Phakic	16	3
	Control 2	Lens status	Pseudophakic	15	2	0.5
			Aphakic	0	0
			Phakic	13	0
	High-risk PVR	Lens status	Pseudophakic	16	5	1
			Aphakic	0	0
			Phakic	11	3
	Control 3	Lens status	Pseudophakic	7	3	0.6
			Aphakic	0	0
			Phakic	16	3
	No risk of PVR	Lens status	Pseudophakic	10	1	0.4
			Aphakic	0	0
			Phakic	13	0

MTX, methotrexate; PVR, proliferative vitreoretinopathy. is significant at <0.05.